Microsaic Systems plc Result of AGM (1434F)
May 15 2017 - 5:42AM
UK Regulatory
TIDMMSYS
RNS Number : 1434F
Microsaic Systems plc
15 May 2017
15 May 2017
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Result of AGM
Microsaic Systems plc (AIM: MSYS), the developer of chip-based
mass spectrometry instruments, announces that at its Annual General
Meeting ("AGM") held on 15 May 2017, all resolutions were duly
passed.
Eric Yeatman, Microsaic's Chairman, commented:
"We are grateful for the support of our shareholders at this
year's AGM.
"As previously announced, Jim Ramage retires today. The board
would like to thank Jim for his contributions to the development of
the Company, both as CEO and previously as a Non-Executive
Director, and we wish him a very happy retirement. Until a new CEO
is selected and in post, the Company will be managed by the
executive team of Chief Operating Officer Glenn Tracey and Finance
Director Bevan Metcalf, and myself as Non-Executive Chairman."
Enquiries:
Microsaic Systems plc
Glenn Tracey, COO
Bevan Metcalf, FD +44 (0) 1483 751577
N+1 Singer (Nominated Adviser &
Broker)
Shaun Dobson
Liz Yong +44 (0)20 7496 3000
Citigate Dewe Rogerson (Financial
PR)
Mark Swallow
Marine Perrier +44 (0)20 7638 9571
About Microsaic Systems
Microsaic Systems plc is a high technology company developing
chip-based, bench-top mass spectrometry ("MS") instruments that are
designed to improve the efficiency of Pharma R&D. MS is an
analytical technique of choice for biochemists across many industry
sectors.
Microsaic aims to bring routine MS analysis to the
pharmaceutical scientist, providing powerful methods of analysis to
enable earlier decision making relating to product identification,
purity and bioactivity.
The Company is working with established global companies in
preparative and purification science with expertise in Pharma and
life sciences to co-develop new, integrated and optimised,
application-specific, solutions to improve productivity in the
development of small molecule and novel biologic (peptides,
antibodies) medicines.
The Microsaic 4000 MiD(R), single quadrupole, is the world's
smallest MS system, retaining the functionality of larger
conventional MS systems, is easier to use by non-specialists,
consumes less energy and has lower running costs. The Company is
also developing new MS systems, based on its patented chip
technologies, to address further areas of emerging need in Pharma
R&D.
Microsaic Systems was established in 2001 by a team including
founders from Imperial College London, and was admitted to AIM in
2011 (ticker: MSYS).
www.microsaic.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGAAMMTMBJBBPR
(END) Dow Jones Newswires
May 15, 2017 06:42 ET (10:42 GMT)
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From Apr 2024 to May 2024
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From May 2023 to May 2024